A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/135 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) A61K 31/5377 (2006.01) A61K 45/06 (2006.01) A61K 49/00 (2006.01) A61K 51/04 (2006.01) C12Q 1/00 (2006.01)
Patent
CA 2266773
The present invention relates to the treatment or prevention of depression and/or anxiety by the administration of a combination of a specific class of NK-1 receptor antagonists and an antidepressant or anti-anxiety agent. The present invention also provides preclinical screens for anxiolytic and antidepressant activity of NK-1 receptor antagonists.
Traitement et prévention de la dépression et des états d'anxiété par l'administration d'une combinaison d'une classe spécifique d'antagonistes du récepteur NK-1, et d'un antidépresseur ou d'un agent anxiolytique. L'invention porte également sur des cribles précliniques pour l'activité anxiolytique et antidépressive des antagonistes du récepteur NK-1.
Carlson Emma Joanne
Rupniak Nadia Melanie
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of a nk-1 receptor antagonist and an antidepressant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of a nk-1 receptor antagonist and an antidepressant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a nk-1 receptor antagonist and an antidepressant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1746856